Here’s a look at some of the latest stock recommendations by analysts. These stocks are expected to return between 18% and 59% as per analysts’ price targets.
Dr Lal Pathlabs
BROKERAGE MORGAN STANLEY Price Target: Rs 2,681 CMP: Rs 2,266 Upside: 18%
- Initiate coverage with ‘overweight’ given strong execution track record, brand recall
- Will sustain share valuations owing to stable revenue growth and profitability
- Stock price catalyst will be suburban diagnostics turnaround in terms of market share gains and margins
HDFC Bank
BROKERAGE BNP PARIBAS Price Target: Rs 2,410 CMP: Rs 1,512 Upside: 59%
- Fears are overdone; current stock level attractive buying opportunity
- Valuation of 2.1 times FY25 core BVPS (book value per share) does scarce justice to FY26 core ROE (return on equity) of 17.1%
- Branch additions will continue despite pressures to conform to Street’s profit expectations
Patel Engineering
BROKERAGE ICICI DIRECT Price Target: Rs 80 CMP: Rs 62.84 Upside: 27%
- Expect order inflows of Rs 6,000 cr in FY25 and Rs 10,000 cr in FY26; Current order book at Rs 19,134 cr
- Non-core asset monetisation and claims could aid in reduction of debt (Rs 1,966 cr in FY23)
- Earnings to grow 32.4% on a compounded basis till FY26
Denial of responsibility! Todays Chronic is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – todayschronic.com. The content will be deleted within 24 hours.